Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Holista Colltech Limited ( (AU:HCT) ) has shared an announcement.
Holista Colltech Limited announced the resignation of Non-Executive Chair David Deloub and Non-Executive Director Loren King, who have provided four weeks’ notice for personal reasons. The company plans to appoint new directors within this period. This change in leadership comes as Holista continues its mission to innovate in the biotech industry, focusing on natural health solutions and advanced collagen technologies, potentially impacting its strategic direction and stakeholder interests.
More about Holista Colltech Limited
Holista Colltech Ltd is a research-driven biotech company formed from the merger of Holista Biotech Sdn Bhd and Colltech Australia Ltd. It is listed on the Australian Securities Exchange and headquartered in Perth, with operations in countries including Malaysia and North America. The company focuses on developing natural solutions for healthier living, offering proprietary solutions for food manufacturers to create healthier products without chemicals, and has expertise in collagen and nano-collagen technologies.
YTD Price Performance: 320.0%
Average Trading Volume: 232,429
Technical Sentiment Signal: Sell
Current Market Cap: A$12M
Find detailed analytics on HCT stock on TipRanks’ Stock Analysis page.